Miquel Serra-Burriel

14PUBLICATIONS
50CO-AUTHORS
Taxation lawPredictive and prognostic markersPharmacogenomicsEuropean Union lawBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jun 24, 2026
The Effects of Compulsory Licensing: A Case Study of HIV Drugs.

|Jun 10, 2026
Colonoscopy versus biennial FIT screening: a post hoc sustained-strategy analysis of the COLONPREV Trial.

|Feb 20, 2026
Sex- and Age-Stratified Outcomes of Colonoscopy Versus Faecal Immunochemical Testing: Post-Analysis of the COLONPREV Study.

Antoni Castells, Enrique Quintero, Miquel Serra-Burriel

|Feb 02, 2026
Quantification of Age and Sex Ratio Differences between Trial and Target Population for New Drugs.

Miquel Serra-Burriel, Paul Schlossmacher, Kerstin Noelle Vokinger

|Jul 07, 2025
Differences Between Trial Populations and Approved Label Populations of New Drugs in the United States and Europe (2012 to 2023) : A Cross-Sectional Study.

Kerstin N Vokinger, Miquel Serra-Burriel, Camille E G Glaus

|Sep 02, 2024
Time From Approval to Reimbursement of New Drugs: A Comparative Analysis Between the United States, England, Germany, France, and Switzerland (2011-2022).

Camille E G Glaus, Miquel Serra-Burriel, Stacie B Dusetzina

Pageof 3

Frequent Collaborators

3 joint publications

Kerstin Noelle Vokinger

2 joint publications

Aaron S Kesselheim

1 joint publications

Matthew Keys

1 joint publications

Carlos Campillo-Artero